CUEのPER（株価収益率）は？

Cue Biopharma（CUE）は現在PER 71.13倍で取引されています。

CUEのROE（自己資本利益率）は？

Cue BiopharmaのROEは-90.35%です。

CUEの配当利回りは？

Cue Biopharmaの配当利回りは0.00%です。

CUEの品質スコア（Quality Score）は？

当社のAIはCUEの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CUEは今が買い時ですか？

当社AIのタイミングスコアは100点中69点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CUEはどのセクターに属しますか？

Cue BiopharmaはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

CUE (NASDAQ) 株価分析 | CUE BIOPHARMA

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

CUE AI Analysis Summary

Our AI summary for CUE: Cue Biopharma (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 71.13, ROE of -90.35%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 69/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CUE

Cue Biopharma

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 26.87

0.03 (0.11%) Day Change

Watchlist Portfolio Compare Chart

71.13

P/E

0.07

D/E

-90.4%

ROE

-63.2%

ROA

0.00%

Div Yield

-1.76

PEG

CUE BIOPHARMA
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 26.87 Price 0.03 (0.11%) Day Change	NEWS SCORE: N/A

CUE, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	26.87
PBV / Sector	5.22 / 44,219.29
Earning Per Share	-4.65

PE / Sector	71.13 / 19.28
PEG or PE/Growth / Sector	-1.76 / 1.23
Average 1M Daily Value	5.58 M GREAT
Average 1W Daily Value	6.72 M

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-59.65 / 98.22
NPM Average (%) / Sector	-1,155.28 / -1,697.63
NPM Change Average (%) / Sector	-61.80 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-63.23 / 185,260.96
ROA Average (%) / Sector	-78.63 / 36,684.70
ROA Change Average (%) / Sector	11.36 / 422,221.66 GOOD
ROE (%) / Sector	-90.35 / 243,762.23
ROE Average (%) / Sector	-128.19 / 48,758.47
ROE Change Average (%) / Sector	18.12 / 424,968.10 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:01:22
Symbol	CUE
Name	CUE BIOPHARMA
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	4.20 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	112.74 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 40 Guest Street, Boston, MA, United States, 02135

Phone: 617 949 2680

Website: https://www.cuebiopharma.com

Sector: Healthcare >> Biotechnology

Description: Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.